| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |